Glycoera

(2)

Veronica Gambillara Fonck and the art of starting again

She helped build GlycoVaxyn, co-founded LimmaTech and became GlycoEra’s founding CEO. Now a partner at Pureos Bioventures, Veronica Gambillara Fonck brings the experience of starting companies to the business of backing them.

veronica-gambillara-fonck · glycoeraRead →

Legend

Founder · Scientist · Executive

Ganesh Kaundinya

Ganesh Kaundinya is President and CEO of GlycoEra, a Swiss-US biotech building extracellular protein degraders to treat autoimmune disease. An MIT-trained chemical engineer, he co-founded Momenta Pharmaceuticals and helped grow it from a sugar-sequencing concept into a public company with FDA-approved products, later acquired by Johnson & Johnson for $6.5 billion. At GlycoEra he raised an oversubscribed $130 million Series B in 2025 to push a precision IgG4 degrader toward the clinic.

glycoera · momenta-pharmaceuticalsRead →